Olympus Co. (OTCMKTS:OLYMY – Get Free Report) was the recipient of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totaling 15,789 shares, a decrease of 66.5% from the November 30th total of 47,099 shares. Based on an average trading volume of 84,770 shares, the short-interest ratio is presently 0.2 days. Based on an average trading volume of 84,770 shares, the short-interest ratio is presently 0.2 days.
Olympus Stock Up 0.2%
Shares of OTCMKTS OLYMY traded up $0.03 during trading hours on Friday, hitting $12.67. The company’s stock had a trading volume of 25,366 shares, compared to its average volume of 109,101. Olympus has a 12 month low of $11.09 and a 12 month high of $15.90. The business has a 50-day simple moving average of $12.91 and a 200-day simple moving average of $12.41.
Olympus Company Profile
Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.
In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.
Further Reading
- Five stocks we like better than Olympus
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Do you know what Amazon is planning for January 1?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.
